| 词条 | BenevolentAI |
| 释义 |
|logo = BenevolentAI logo.png | type = Private | industry = Artificial intelligence Health care Neuroscience | founded = November 13, 2013 | hq_location_city = London, England | key_people = Brent Gutekunst, Ivan Griffin, Ken Mulvany, Michael Brennan, CEO, Baroness Joanna Shields | num_employees = 200 – 250 }}BenevolentAI is a UK-based artificial intelligence company. They operate under the mission to change the way medicine is designed, developed, tested, and delivered to the market using computational medicine and AI technology.[1] It is a fully integrated AI company with pharmaceutical discovery and clinical development capabilities.[2] The company has developed the Benevolent Platform, a machine learning platform for drug discovery.[3] The Benevolent Platform ingests and analyses unstructured and structured biomedical information, combines it with deep learning to create a bioscience knowledge graph coupled with an automated platform for hypothesis generation and validation.[4] Company historyBenevolentAI was founded in November 2013 by Ken Mulvany.[5] Initially the company focussed on the development of a cross-functional AI technology to incorporate basic science, chemistry and clinical components and to design a system that could ingest, read and contextualise the bioscience information.[6] Throughout the course of 2014 and 2015 the technology was further developed to also reason and propose hypotheses to treat disease. By 2015, the company had raised $87 million in funding, including investors like Woodford Investment Management and Lansdowne Partners.[7] In 2015 BenevolentAI began to fully apply its technology to drug discovery and development and announced the appointment of Jackie Hunter to lead bioscience research at the company.[8] During 2016 further early drug R&D programmes were established and an in-license deal completed with J&J for novel clinical stage drug candidates.[9] That year BenevolentAI also initiated their first full drug programmes for ALS.[10] 2017 saw the company file its first Investigational New Drug (IND) application. In February 2018, BenevolentAI acquired a Cambridge research facility in order to expand its capabilities across the entire drug discovery process. Two months later the company announced a further round of funding for $115 million.[11] In May of 2018, the company announced it had appointed Joanna Shields as CEO.[12] The company is presently headquartered in Warren Street, London with a research facility in Cambridge (UK) and additional offices based in New York and Belgium.[13] On keeping the company headquartered in London, founder Mulvany has said "There's a real opportunity to build a business in this country, and there's an opportunity for the country to lead this sector, and all the pieces are in place. We've got incredible scientists, incredible mathematicians, we're able to draw all these people into London."[14] BenevolentAI has active R&D drug programmes from discovery to PhaseIIb in disease areas such as ALS, Parkinson's, ulcerative colitis and sarcopenia.[15] Horizons Ventures advisor Bart Swanson is a board member; shareholders include Richard Farleigh, a high profile angel investor.[16] Solutions and servicesIn 2016 BenevolentAI became the first European company to use a deep learning supercomputer to assist in the process of drug discovery, using the DGX-1 supercomputer to support its Judgment Augmented Correlation System (JACS).[17] Their Platform is designed to design new molecules and extract hypotheses based on a knowledge graph detailing the relationships between genes, targets, diseases, proteins, and drugs.[18] The company has announced it is working with the Sheffield Institute of Translational Neuroscience on a treatment for ALS.[19] BenevolentAI AwardIn 2017 BenevolentAI announced the creation of the BenevolentAI Award, in partnership with the Association of Medical Research Charities. The award is given to a single applicant a year, allowing the winner to access the company's technology to accelerate their medical research using artificial intelligence.[20] The winner of the 2018 award was a collaboration between the Parkinson's UK and The Cure Parkinson's Trust. Upon receiving the award, the group announced their aim to identify three treatments that can be repurposed for Parkinson's and two novel drug targets.[21] Awards and recognitions
References1. ^{{cite web |title=About Us |url=https://benevolent.ai/about-us |website=BenevolentAI |accessdate=27 November 2018}} 2. ^{{cite web |title=BenevolentAI Raises $115 Million to Extend Its Leading Global Position in the Field of AI Enabled Drug Development |url=https://www.prnewswire.com/news-releases/benevolentai-raises-115-million-to-extend-its-leading-global-position-in-the-field-of-ai-enabled-drug-development-680180573.html |website=PR Newswire |accessdate=27 November 2018}} 3. ^{{cite web |last1=Liu |first1=Angus |title=BenevolentAI's Proximagen buy creates first AI firm capable of entire drug R&D |url=https://www.fiercebiotech.com/biotech/proximagen-buy-creates-first-ai-firm-capable-entire-drug-r-d-benevolentai |website=Fierce Biotech |publisher=Questex |accessdate=25 November 2018}} 4. ^{{cite web |last1=Shields |first1=Joanna |title=Why we need to use AI for life not just lifestyle |url=https://benevolent.ai/blog/why-we-need-to-use-ai-for-life-not-just-lifestyle1 |website=BenevolentAI |publisher=BenevolentAI |accessdate=26 November 2018}} 5. ^{{cite web |last1=Lunden |first1=Ingrid |title=BenevolentAI, which uses AI to develop drugs and energy solutions, nabs $115M at $2B valuation |url=https://techcrunch.com/2018/04/18/benevolentai-which-uses-ai-to-develop-drugs-and-energy-solutions-nabs-115m-at-2b-valuation/ |website=TechCrunch |publisher=TechCrunch |accessdate=20 November 2018}} 6. ^{{cite web |last1=BenevolentAI |title=BenevolentAI Raises $115 Million to Extend Its Leading Global Position in the Field of AI Enabled Drug Development |url=https://www.prnewswire.com/news-releases/benevolentai-raises-115-million-to-extend-its-leading-global-position-in-the-field-of-ai-enabled-drug-development-680180573.html |website=PR Newswire |publisher=Cision |accessdate=25 November 2018}} 7. ^{{cite web |last1=Taylor |first1=Nick Paul |title= MedTech BenevolentAI bags $115M to fuel AI-enabled R&D push |url=https://www.fiercebiotech.com/medtech/benevolentai-bags-115m-to-fuel-ai-enabled-r-d-push |website=Fierce Biotech |publisher=Questex |accessdate=28 November 2018}} 8. ^{{cite web |last1=BenevolentAI |title=BenevolentAI, the pioneering London-based company using artificial intelligence to advance pharmaceutical development, appoints head of BBSRC as new Chief Executive |url=https://benevolent.ai/news/announcements/benevolentai-appoints-jackie-hunter-as-ceo-of-benevolentbio |website=BenevolentAI |publisher=BenevolentAI |accessdate=23 November 2018}} 9. ^{{cite web |title=Exclusive license agreement with Janssen for clinical stage drug candidates |url=https://benevolent.ai/news/announcements/british-artificial-intelligence-firm-announces-exclusive-license-agreement-with-janssen |website=BenevolentAI |publisher=BenevolentAI |accessdate=24 November 2018}} 10. ^{{cite web |title=AI enabled research shows delay in onset of motor neurone disease |url=https://benevolent.ai/news/announcements/ai-enabled-research-shows-delay-in-onset-of-motor-neurone-disease |website=BenevolentAI |publisher=BenevolentAI |accessdate=23 November 2018}} 11. ^{{cite web |last1=Reuters |title=AI drug hunter BenevolentAI worth $2 billion after fund raising |url=https://www.euronews.com/2018/04/19/ai-drug-hunter-benevolentai-worth-2-billion-after-fund-raising |website=EuroNews |publisher=EuroNews |accessdate=28 November 2018}} 12. ^{{cite web |last1=Shead |first1=Sam |title=BenevolentAI Makes Joanna Shields New CEO |url=https://www.forbes.com/sites/samshead/2018/05/01/benevolentai-makes-joanna-shields-new-ceo/#54c99605b9cd |website=Forbes |publisher=Forbes |accessdate=27 November 2018}} 13. ^{{cite web |last1=Medeiros |first1=João |title=This AI unicorn is disrupting the pharma industry in a big way |url=https://www.wired.co.uk/article/benevolent-ai-london-unicorn-pharma-startup |website=WIRED |publisher=WIRED |accessdate=26 November 2018}} 14. ^{{cite web |last1=Shona |first1=Ghosh |title=A British tech unicorn is trying to cure Alzheimer's and ALS with artificial intelligence |url=https://www.businessinsider.com/benevolent-ai-ceo-ken-mulvany-interview-2017-4 |website=Business Insider |publisher=Business Insider |accessdate=25 November 2018}} 15. ^{{cite web |last1=Brackley |first1=Paul |title=BenevolentAI founder Ken Mulvany on using artificial intelligence to find new drugs to tackle disease |url=http://www.cambridgeindependent.co.uk/business/science/benevolentai-founder-ken-mulvany-on-using-artificial-intelligence-to-find-new-drugs-to-tackle-disease-1-5429242 |website=Cambridge Independent |publisher=Cambridge |accessdate=26 November 2018}} 16. ^{{cite web |last1=Ghosh |first1=Shona |title=A British tech unicorn is trying to cure Alzheimer's and ALS with artificial intelligence |url=https://www.businessinsider.com/benevolent-ai-ceo-ken-mulvany-interview-2017-4 |website=Business Insider |publisher=Business Insider |accessdate=26 November 2018}} 17. ^{{cite web |last1=Staines |first1=Richard |title=AI firm aims to revolutionise drug R&D with new UK facility |url=https://pharmaphorum.com/news/benevolentai-revolutionise-drug-rd-new-facility/ |website=pharmaphorum |publisher=pharmaphorum |accessdate=26 November 2018}} 18. ^{{cite web |last1=BenevolentAI |title=BenevolentAI Raises $115 Million to Extend Its Leading Global Position in the Field of AI Enabled Drug Development |url=https://www.prnewswire.com/news-releases/benevolentai-raises-115-million-to-extend-its-leading-global-position-in-the-field-of-ai-enabled-drug-development-680180573.html |website=Pr Newswire |publisher=Cision |accessdate=26 November 2018}} 19. ^{{cite web |last1=Rossi |first1=Ben |title=AI provides breakthrough in treatment for motor neuron disease |url=https://www.information-age.com/ai-provides-breakthrough-treatment-motor-neuron-disease-123466452/ |website=Information Age |publisher=Bonhill |accessdate=23 November 2018}} 20. ^{{cite web |title=Annual award announced for medical research charities wishing to benefit from artificial intelligence |url=https://benevolent.ai/news/announcements/medical-ai-award-sets-its-sights-on-treating-parkinsons |website=BenevolentAI |publisher=BenevolentAI |accessdate=28 November 2018}} 21. ^{{cite web |last1=Hughes |first1=Owen |title=British AI firm lends smarts to Parkinson's charities in hunt for new treatments |url=https://www.digitalhealth.net/2018/04/benevolent-ai-lens-artificial-intelligence-platform/ |website=Digital Health |publisher=Digital Health |accessdate=28 November 2018}} 22. ^{{cite web |title=CB Insights Reveals the AI 100 List At The Innovation Summit |url=https://www.prnewswire.com/news-releases/cb-insights-reveals-the-ai-100-list-at-the-innovation-summit-610394035.html |website=PR Newswire |publisher=Automat Technologies, Inc |accessdate=28 November 2018}} 23. ^{{cite web |title=BRITAIN'S FASTEST-GROWING PRIVATE TECH COMPANIES REVEALED |url=http://www.fasttrack.co.uk/wp-content/uploads/2017-Sunday-Times-Hiscox-Tech-Track-100-National-press-release.pdf |website=Fast Track |accessdate=28 November 2018}} 24. ^{{cite web |title=Winners 2017 |url=https://awards.cphi.com/winners/2017-winners/ |website=CPhI Pharma Awards |publisher=UBM |accessdate=28 November 2018}} 25. ^{{cite web |title=THE HOTTEST TECH STARTUPS OF 2017 ROCKED LONDON AT THE EUROPAS AWARDS |url=https://theeuropas.com/2017/06/16/the-hottest-tech-startups-of-2017-rocked-london-at-the-europas-awards/ |website=The Europas |publisher=The Europas |accessdate=28 November 2018}} 26. ^{{cite web |title=Awards Finalists |url=https://cogx.co/2018-awards-finalists/ |website=CogX |publisher=CogX |accessdate=28 November 2018}} 27. ^{{cite web |title=BenevolentAI Awarded Technology Pioneer Status by World Economic Forum |url=https://benevolent.ai/news/benevolentai-awarded-technology-pioneer-status-by-world-economic-forum |website=BenevolentAI |publisher=BenevolentAI |accessdate=28 November 2018}} 3 : Artificial intelligence|Companies of the United Kingdom|Health informatics |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。